Akiko Masumoto

826 total citations
20 papers, 451 citations indexed

About

Akiko Masumoto is a scholar working on Cardiology and Cardiovascular Medicine, Epidemiology and Surgery. According to data from OpenAlex, Akiko Masumoto has authored 20 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cardiology and Cardiovascular Medicine, 10 papers in Epidemiology and 6 papers in Surgery. Recurrent topics in Akiko Masumoto's work include Cardiac Valve Diseases and Treatments (10 papers), Infective Endocarditis Diagnosis and Management (5 papers) and Aortic Disease and Treatment Approaches (3 papers). Akiko Masumoto is often cited by papers focused on Cardiac Valve Diseases and Treatments (10 papers), Infective Endocarditis Diagnosis and Management (5 papers) and Aortic Disease and Treatment Approaches (3 papers). Akiko Masumoto collaborates with scholars based in Japan and United States. Akiko Masumoto's co-authors include Martin E. Hemler, Ichiro Imoto, H Nanri, Akinari Tabaru, Masahiro Ikeda, Makoto Otsuki, Yutaka Furukawa, Hironori Sakai, Chiyo Sato and Takaaki Ohmori and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Cell Biology and Journal of Thoracic and Cardiovascular Surgery.

In The Last Decade

Akiko Masumoto

17 papers receiving 447 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Akiko Masumoto Japan 7 307 108 106 101 101 20 451
S G Slade United States 8 300 1.0× 203 1.9× 76 0.7× 120 1.2× 300 3.0× 8 634
Dalia Gilat Israel 10 230 0.7× 45 0.4× 62 0.6× 170 1.7× 181 1.8× 14 510
S. Yasue Japan 9 87 0.3× 75 0.7× 86 0.8× 119 1.2× 122 1.2× 14 380
R Eisman United States 6 417 1.4× 123 1.1× 487 4.6× 156 1.5× 120 1.2× 6 749
J Sorvillo United States 12 91 0.3× 91 0.8× 51 0.5× 177 1.8× 104 1.0× 13 456
Beate Böhm Germany 14 106 0.3× 50 0.5× 63 0.6× 139 1.4× 236 2.3× 23 519
T Nakano Japan 12 143 0.5× 89 0.8× 21 0.2× 179 1.8× 217 2.1× 20 477
Manuela Buzoianu United States 9 103 0.3× 63 0.6× 28 0.3× 143 1.4× 88 0.9× 14 524
F S Rosen United States 11 101 0.3× 35 0.3× 112 1.1× 211 2.1× 214 2.1× 16 559
Ken Nguyen United States 7 53 0.2× 27 0.3× 60 0.6× 263 2.6× 127 1.3× 12 526

Countries citing papers authored by Akiko Masumoto

Since Specialization
Citations

This map shows the geographic impact of Akiko Masumoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Akiko Masumoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Akiko Masumoto more than expected).

Fields of papers citing papers by Akiko Masumoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Akiko Masumoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Akiko Masumoto. The network helps show where Akiko Masumoto may publish in the future.

Co-authorship network of co-authors of Akiko Masumoto

This figure shows the co-authorship network connecting the top 25 collaborators of Akiko Masumoto. A scholar is included among the top collaborators of Akiko Masumoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Akiko Masumoto. Akiko Masumoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamamoto, Hiroyuki, Akiko Masumoto, Nobuyuki Takahashi, et al.. (2024). Efficacy of Native T<sub>1</sub> Mapping for Patients With Non-Ischemic Cardiomyopathy and Ventricular Functional Mitral Regurgitation Undergoing Transcatheter Edge-to-Edge Repair. Circulation Journal. 88(4). 519–527. 3 indexed citations
2.
3.
Masumoto, Akiko, et al.. (2023). Impact of antithrombotic therapy on clinical outcomes in patients with type B acute aortic syndrome. JTCVS Open. 14. 36–45. 2 indexed citations
4.
Yamamoto, Hiroyuki, Nobuyuki Takahashi, Tetsuari Onishi, et al.. (2023). Rapidly progressive infective endocarditis after MitraClip therapy: A rare complication of transcatheter edge-to-edge mitral valve repair. Journal of Cardiology Cases. 27(6). 279–282.
5.
Masumoto, Akiko, et al.. (2023). Ventilator-assisted transcatheter edge-to-edge mitral valve repair for severe atrial functional mitral regurgitation: a case report. European Heart Journal - Case Reports. 7(3). ytad101–ytad101.
6.
Masumoto, Akiko, Hiroyuki Yamamoto, Nobuyuki Takahashi, & Tomofumi Takaya. (2022). A large iatrogenic tearing of atrial septal defect after MitraClip implantation: a rare and cautionary complication during transcatheter edge-to-edge mitral valve repair. European Heart Journal - Case Reports. 6(4). ytac119–ytac119. 1 indexed citations
7.
8.
Masumoto, Akiko, Takeshi Kitai, Shingo Matsumoto, et al.. (2021). Impact of serum lactate dehydrogenase on the short-term prognosis of COVID-19 with pre-existing cardiovascular diseases. Journal of Cardiology. 79(4). 501–508. 10 indexed citations
9.
Kitai, Takeshi, et al.. (2021). Optimal Timing of Surgery for Patients with Active Infective Endocarditis. Cardiology Clinics. 39(2). 197–209. 4 indexed citations
10.
Kaji, Shuichiro, Akiko Masumoto, Kitae Kim, et al.. (2021). Aortic enlargement in two weeks is associated with subsequent aortic events in patients with type B acute aortic syndrome. Journal of Thoracic and Cardiovascular Surgery. 166(2). 410–418.e1. 4 indexed citations
11.
Masumoto, Akiko, Takeshi Kitai, Mitsuhiko Ota, et al.. (2020). Real-time observation of a high-echoic mass in the left ventricle during transcatheter aortic valve implantation: a case report. European Heart Journal - Case Reports. 4(6). 1–4. 1 indexed citations
12.
Masumoto, Akiko, Shunsuke Kubo, Masanobu Ohya, Takeshi Maruo, & Kazushige Kadota. (2019). MitraClip Therapy for Dynamic Mitral Regurgitation With Repetitive Heart Failure Exacerbation. JACC: Cardiovascular Interventions. 12(24). e215–e217. 2 indexed citations
13.
Nakamuta, Makoto, et al.. (2004). Body surface area is an independent factor contributing to the effects of lamivudine treatment. Hepatology Research. 31(1). 13–17. 5 indexed citations
14.
15.
Masumoto, Akiko, et al.. (1997). Transient multiple hepatic nodules with marked infiltration of eosinophils caused by ascariasis.. PubMed. 92(5). 897–8. 1 indexed citations
16.
Masumoto, Akiko, H Nanri, Akinari Tabaru, et al.. (1997). High plasma concentrations of nitrite/nitrate in patients with hepatocellular carcinoma.. PubMed. 92(9). 1520–3. 42 indexed citations
17.
Masumoto, Akiko & Martin E. Hemler. (1993). Mutation of putative divalent cation sites in the alpha 4 subunit of the integrin VLA-4: distinct effects on adhesion to CS1/fibronectin, VCAM-1, and invasin.. The Journal of Cell Biology. 123(1). 245–253. 100 indexed citations
18.
Masumoto, Akiko & Martin E. Hemler. (1993). Multiple activation states of VLA-4. Mechanistic differences between adhesion to CS1/fibronectin and to vascular cell adhesion molecule-1.. Journal of Biological Chemistry. 268(1). 228–234. 244 indexed citations
19.
Fukutomi, Takayoshi, et al.. (1992). Clinical significance of the serum levels of the 7S domain of type IV collagen in patients with primary biliary cirrhosis. Journal of Gastroenterology and Hepatology. 7(6). 596–601. 9 indexed citations
20.
Masumoto, Akiko, et al.. (1991). Effect of insulin, glucagon or dexamethasone on the production of insulin-like growth factor I in cultured rat hepatocytes.. PubMed. 82(4). 136–41. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by S G Slade Breakdown of academic impact, for papers by Dalia Gilat Breakdown of academic impact, for papers by S. Yasue Breakdown of academic impact, for papers by R Eisman Breakdown of academic impact, for papers by J Sorvillo Breakdown of academic impact, for papers by Beate Böhm Breakdown of academic impact, for papers by T Nakano Breakdown of academic impact, for papers by Manuela Buzoianu Breakdown of academic impact, for papers by F S Rosen Breakdown of academic impact, for papers by Ken Nguyen
Rankless by CCL
2026